Indexed by Science Citation Index (SciSearch), International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals (DOAJ), African Journal Online, Bioline International, Open-J-Gate

ISSN: 1596-5996 (print); 1596-9827 (electronic)-


Home | Back Issues | Current Issue | Review manuscript | Submit manuscript

 
 

This Article

 

Abstract

 

Full-Text (PDF)

 

Table of contents

 

Comments

 

Letters

 

Comments to Editor

 

e-mail Alert

 

Sign Up

 

Research Article


 

Oral Methylated N-Aryl Chitosan Derivatives for Inducing Immune Responses to Ovalbumin  

Tittaya Suksamran1, Jariya Kowapradit1, Tanasait Ngawhirunpat1, Theerasak Rojanarata1, Warayuth Sajomsang2, Tasana Pitaksuteepong3 and Praneet Opanasopit1*

1Pharmaceutical Development of Green Innovations Group (PDGIG), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, 2National Nanotechnology Center, Thailand Science Park, Pathumthani, 3Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand

*For correspondence: Email: praneet@su.ac.th  Tel: +66-34-255800; Fax: +66-34-255801

Received: 8 April 2012                                                        Revised accepted: 5 November 2012

Tropical Journal of Pharmaceutical Research, December 2012; 11(6): 899-908

http://dx.doi.org/10.4314/tjpr.v11i6.5  

Abstract

 

Purpose: To investigate different structures of modified chitosan containing different chain lengths and aromatic moieties for vaccine delivery capacity.

Methods: The characteristics of the modified chitosan, namely, methylated N-(4-N,N-dimethylaminobenzyl) chitosan (TM-Bz-CS), methylated N-(4-N,N-dimethylaminocinnamyl) chitosan (TM-CM-CS) and methylated N-(4-pyridinylmethyl) chitosan (TM-Py-CS), with Eqiva degree (equivalent degree) were studied by in vitro absorption enhancement on the transepithelial electrical resistance (TEER) in Caco-2 cell monolayers as well as by in vivo adjuvant activity against ovalbumin (OVA), a model antigen, via oral administration to BALB/c mice.

Results: At the same concentration and pH (0.1 mg/ml, pH 7.4), TM65CM50CS exhibited the highest in vitro enhancing paracellular permeability and also the highest in vivo adjuvant activity following oral administration to mice. OVA-specific serum immunoglobulin G (IgG) antibody levels of mice that received OVA in TM65CM50CS were significantly (p < 0.05) higher than those that received OVA in TM65CS, TM56Bz42CS and TM53Py40CS. On the other hand, TM65CS and TM56Bz42CS exhibited in vitro enhancing paracellular permeability but showed no immune responses, while TM53Py40CS failed to enhance paracellular permeability and did not elicit immune responses as well.

Conclusion: This study demonstrates that addition of hydrophobic moiety (dimethylaminocinnamyl) to CS backbone can increase both its absorption enhancing property and adjuvant activity. The chemical structure and the positive charge location play an important role for binding affinity, absorption enhancement and immune responses.

 

Keywords: Chitosan derivatives; Absorption enhancement; Oral vaccine delivery; Immunoadjuvants; Ovalbumin.

Copyright@2002-2010. Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City. All rights reserved.

Powered by Poracom E-mail: jmanager@poracom.net